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Abstract
Louis Pasteur once commented on the happiness that a scientist finds when, besides making a discovery, study
results find practical application. Where health status is poor and resources are limited, finding such applications is a
necessity, not merely a joy.
Dissemination, or the distribution of new knowledge gained through research, is essential to the ethical conduct of
research. Further, when research is designed to improve health, dissemination is critical to the development of
evidence-based medicine and the adoption of evidence-supported interventions and improved practice patterns
within specific settings. When dissemination is lacking, research may be considered a waste of resources and a
useless pursuit unable to influence positive health outcomes.
Effective translation of the findings of health research into policy and the practice of medicine has been slow in many
countries considered low or lower middle-income (as defined by the World Bank). This is because such countries often
have health care systems that are under-resourced (e.g., lacking personnel or facilities) and thus insufficiently responsive
to health needs of their populations. However, implementation research has produced many tools and strategies that
can prompt more effective and timelier application of research findings to real world situations.
A conscientious researcher can find many suggestions for improving the integration of research evidence into practice.
First and foremost, the truthful reporting of results is emphasized as essential because both studies with desirable
findings as well those with less than ideal results can provide new and valuable knowledge. Consideration in advance
of the audience likely to be interested in study findings can result in suitable packaging and targeted communication
of results. Other strategies for avoiding the barriers that can negatively impact implementation of research evidence
include the early involvement of stakeholders as research is being designed and discussion before initiation of
proposed research with those who will be affected by it. It is also important to recognize the role of education and
training for ensuring the skills and knowledge needed for not only the conduct of high quality research but also for
the meaningful promotion of results and application of research findings to achieve intended purposes.
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interventions
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“To him who devotes his life to science, nothing can
give more happiness than increasing the number of
discoveries, but his cup of joy is full when the results
of his studies immediately find practical applications.”
Louis Pasteur
Background on dissemination and
implementation
One of the inherent responsibilities of the ethical conduct
of research is dissemination or the targeted distribution of
newly acquired knowledge gained through research.
When research is designed to improve health, dissemin-
ation of findings can be related to the following four
ethical principles:
 Responsible use of public dollars,
 Benefit to participants/their cohorts/the public,
 Contributions to evidence-based knowledge and
practice that maximize benefit and avert harm,
 Amelioration of health disparities [1].
The development of evidence-based medicine is
dependent on dissemination. Further, when researchers
examine their findings in the light of other published
data supporting similar conclusions, this can create a
platform for making clinical and policy decisions
designed to improve health outcomes. When reporting
research results, it is important to clearly state if an
intervention produced its expected outcome. Level of
certainty associated with the conclusion should also be
indicated utilizing established criteria.
Research designed to improve patient care and health
status is often directed at assessment of efficacy or
effectiveness. Randomized controlled trials are most
useful for determining efficacy of an intervention and its
ability to produce therapeutic impact while evaluation of
effectiveness is reliant on pragmatic trials that suggest
how a given intervention or treatment may or may not
work in a real-world situation. In the context of such
health-related research, dissemination is essential and
necessarily intertwined with implementation, or “the use
of strategies to adopt and integrate evidence-based
health interventions and change practice patterns within
specific settings [2].”
When drafting public policy, important variables of
risk versus benefit are typically addressed, and the ana-
lysis should be supported by evidence. However, findings
are often modulated by the projected costs associated
with both implementation and dissemination; this is
especially true in under-resourced settings. Additionally,
factors associated with individuals expected to imple-
ment recommended strategies, as well as organizational
factors, can impede integration of findings into practice,
even when findings are based upon strong evidence.
Implementation of findings can also take much longer
than desirable and use of findings can be compromised
when research is conducted without consideration of
“real world” situations.
A concrete example of effective dissemination of
evidence-based knowledge to expand the use of practices
and achieve desirable outcomes is the Baby-Friendly
Hospital Initiative (BFHI) [3]. A draft systematic review
was prepared by the Evidence-based Practice Center and
released by the US Agency for Healthcare Research and
Quality for peer review. This systematic review rated the
evidence for the effectiveness of this strategy in terms of
influencing desirable outcomes as moderately strong [4].
While there is little disagreement about the benefits
associated with the indicated outcomes of increasing rates
of breastfeeding initiation, exclusivity for the first 6 months
of an infant’s life, and continued duration for at least a
year, not all babies are born into breastfeeding-friendly,
hospital environments. Thus, there is the need for more
research to determine other cost-effective means to
achieve behavioral change among mothers and caregivers
and to confirm the necessary conditions to improve both
infant and maternal breastfeeding outcomes. This need is
the reason that Thomas Jefferson University and research
colleagues of Jawaharlal Nehru Medical College (JNMC),
Belagavi (Karnataka, India) are conducting an exploratory
study to assess if the involvement of peer counselors and
use of mobile health (mHealth) educational tools have the
potential for achieving greater adherence to evidenced-
based breastfeeding recommendations.
Why are dissemination and implementation
research as well as diffusion research important?
Green and colleagues describe the approach that has
been used to generate evidence-based guidelines to
improve patient care as linear and funnel-like. Such an
approach results when scientists undertake successive
research to amass a large body of evidence which is then
vetted and disseminated to policy makers and practi-
tioners [5]. The linear approach has been challenged as
it can be time-consuming and less than ideal, especially
for under-resourced countries where health disparities
are significant and delay in finding solutions to serious
health problems can adversely affect many lives. Balas
and Boren made the assertion in 2000 that it takes an
estimated 17 years to fully integrate the results of
research into practice and that typically only 14% of
original research is used to the benefit of patient care
[6]. While the time lag may have narrowed somewhat in
recent years, the period of time for the translation of
research into practice is generally considered too long.
The low percentage of research successfully integrated
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into practice and used to improve care is also concern-
ing. Critics have also suggested that efficacy research,
best embodied by new drug trials, is often conducted in
a manner that is not reflective of “real world” situations.
For example, new drug trials are usually conducted on
patients with no co-morbidities, an uncommon situation
in many clinical practices.
Fortunately, an emphasis has been placed in recent
years on the development of researchers who can focus
on these types of problems and carry out implementa-
tion research or “the scientific inquiry into questions
concerning implementation—the act of carrying an
intention into effect, which in health research can be
policies, programmes, or individual practices (collect-
ively called interventions) [7].” This type of research is
generally concerned with the users of research findings,
not merely with the production of knowledge. Imple-
mentation research is important because it can inform:
 Quality improvement strategies,
 People who are influenced to change their behavior
to have a healthier life,
 Communities who wish to change their condition [7].
Inadequate communication and dissemination can be
a barrier to timely and effective implementation of
research findings. Therefore, dissemination research is
another means for increasing the probability of moving
research discoveries to sustained adoption. This type of
research has been defined as “the systematic study of
how the targeted distribution of information and inter-
vention materials to a specific public health audience
can be successfully executed so that increased spread of
knowledge about the evidence-based public health
interventions achieves greater use and impact of the
intervention [8].”
Another type of research that has been discussed in
dissemination and implementation literature is diffusion
research, which involves “the systematic study of the
factors necessary for successful adoption by stakeholders
and the targeted population of an evidence-based inter-
vention which results in widespread use (e.g., at the state
or national level) and specifically includes the uptake or
the penetration of broad scale recommendations through
dissemination and implementation efforts, marketing,
laws and regulations, systems research and policies [8].”
Such research can be useful for detailing a plan that, if
implemented, could have impact on a macro level.
Does strong evidence ensure widespread
relevance and adoption?
There is no shortage of examples from published work,
including that resulting from our research in India, that
the answer to this question is no. Research sponsored by
the National Institute of Child Health and Human De-
velopment’s Global Network for Women’s and Children’s
Health Research was conducted during the early 2000s
in the Belagavi District of Karnataka State, India in a re-
search area surrounding our research partner, Jawaharlal
Nehru Medical College (JNMC). The research docu-
mented that misoprostol tablets given sublingually to
mothers delivering in the home (the primary delivery lo-
cation in India at the time) was 80% effective in reducing
severe postpartum hemorrhage, for a cost of pennies per
dose [9]. Although evidence was strong, why is it that
the drug was not universally employed in similar settings?
Will positive findings from the recently completed study
of room-temperature-stable carbetocin suffer a similar
fate? Or are there advocates who will disseminate findings
showing that this uterotonic is especially efficacious for re-
ducing postpartum hemorrhage? Will product champions
emerge and utilize critical resources to ensure availability
of carbetocin and its successful use, when appropriate?
Publications continue to repeat the adage, “We know
what kills pregnant women and babies, and we know
what will prevent most of their deaths.” Yet, countries
are handicapped in implementing programs that work
and are sustainable. Why? It is critical to ask this ques-
tion as a means of removing the barriers to full imple-
mentation of evidence-based practices and achieving
programmatic sustainability.
Throughout most of the world, the three leading
causes of maternal mortality remain postpartum
hemorrhage, hypertensive disorders of pregnancy, and
sepsis. The research team at JNMC, in collaboration
with US and UK partners, have performed extensive re-
search in the first two areas of pregnancy complications
[9–14] and are about to embark on studies tied to the
prevention and early diagnosis of puerperal sepsis.
In the developed world (generally considered countries
in the World Bank’s higher income categories),
evidence-based protocols and policies have been estab-
lished for the appropriate use and availability of multiple
uterotonic agents, for assuring adequate access to pre-
natal care and an appropriate schedule of visits to detect
and address pregnancy complications, and for promoting
a concern for sterile technique and the indicated use of
antibiotics. Adherence to these protocols and policies
contribute to the relatively low rates of adverse preg-
nancy outcomes in developed countries. But introduc-
tion of similar protocols and policies may be met with
resistance among health care providers in an under-
resourced country or have little impact due to other
barriers. Distribution of information about the research
providing the evidence won’t be enough if no effort has
been made to accommodate differences in the practice
settings and provider capabilities between research sites
and the under-resourced country.
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Health research has increased in developing countries
in recent years, resulting in the generation of many
interventions proven to have beneficial impact on health
status. However, knowledge about how to achieve scale-
up, widespread dissemination and sustainability has not
kept pace. Clearly, there is a need for dissemination and
implementation research to narrow the gap between
research and practice.
Is dissemination applicable to research with
unexpected or negative findings?
Dissemination remains a responsibility of investigators
despite unexpected or negative research findings because
such research can generate new knowledge, stimulate
further research, and advance the search for solutions to
significant health problems. An example which illus-
trates the importance of global health research and the
need to recognize how local practices and infrastructures
can affect outcomes is the recently published article, “A
population-based, multifaceted strategy to implement
antenatal corticosteroid treatment versus standard care
for the reduction of neonatal mortality due to preterm
birth in low-income and middle-income countries: the
ACT cluster-randomized trial.” The study was designed
to increase corticosteroids use among women who were
at increased risk for a preterm birth. Since there was no
debate about the efficacy of employing corticosteroids to
reduce neonatal mortality in the developed world, this
Global Network trial primarily focused on implementation
and effectiveness. Despite increased use of antenatal
corticosteroids among women delivering low-birthweight
infants in the intervention group, neonatal mortality did
not decrease in this group. Further, study results showed a
surprising increase in harm among users of standard
corticosteroid dosing [15]. Appropriately, these findings
were responsible for delaying widespread promotion of
the drug and stimulating additional research to
determine why use of antenatal corticosteroids are
associated with improved preterm birth outcomes in
developed countries and what additional components
should be added to an intervention strategy based upon
antenatal corticosteroid use to achieve comparable
results in low-resource settings.
Research can also identify interventions which achieve
a desired outcome but also cause unintended conse-
quences or compete long-term with the desired out-
comes–e.g., increasing rates of non-indicated cesarean
sections and inappropriate, widespread use of antibiotics.
These are two practices, among many others, which may
work at cross-purposes with the very effect that is
desired. To report only findings with favorable impact
and ignore dissemination of findings of harm would be a
violation of principles associated with the ethical
conduct of research involving human subjects.
What can be done to increase the implementation
of research findings and sustain the changes that
are implemented as a result of research evidence?
Successful programmatic initiatives often begin at the
top level, where executive leadership control available
dollars, and then move downwards. Nevertheless, the
importance of widespread education, relevant training
and community mobilization cannot be overemphasized,
and implementation research can be beneficial by focus-
ing on the desired end-point and engaging those in the
community whose support is required.
Our research initiatives in India have shown the importance
of empowering community health workers as first-line team
players in both the education of soon-to-be as well as pres-
ently pregnant women. Further, involvement of these village-
based health workers in the early identification of women at
risk for health complications has proven beneficial. Neverthe-
less, adequate dissemination of the knowledge gained through
our research is necessary to influence scale-up and widespread
diffusion to areas in India beyond our research area.
A growing body of peer-reviewed literature offers advice
for translating science into evidence-based healthcare be-
haviors and practices that promote and improve health
and can be sustained. Those writing about implementa-
tion science agree that success requires recognition that
implementation spans multiple stages. Fixsen and col-
leagues suggested six implementation stages: exploration/
adoption, installation, initial implementation, full imple-
mentation, innovation, and sustainability, [16] while
Saldana specifies only three stages: pre-implementation,
implementation, sustainability [17]. Despite variation in
the number and description of stages, relevant publica-
tions identify similar activities or steps, which are consid-
ered essential for integration of research evidence into
practice. Table 1 below provides recommendations and
examples of activities that Woolf et al. have offered to
increase implementation success.
Table 2 presents useful recommendations that were
developed by Glasgow and Emmons to enhance the
movement of research into practice.
Table 1 Recommendations for ensuring translation of research
into health improvements [19]
Determine the user audience(s) for the research, define a user-oriented
research agenda and appreciate the environment in which the users operate;
Utilize objective methods of data collection and analysis and present
data with sufficient transparency to establish trustworthiness;
Package findings in a format appropriate for the audience and utilizing
principles from graphic design, communication science, marketing, and
the psychology of information processing;
Engage stakeholders that have interest in an outcome and give voice to
those who will be most directly affected before the research begins;
Use effective communication science during interactions with decision
makers, stakeholders and the public and reach the target audience(s)
with the right message through the appropriate media.
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Strategies for integration of research into practice can
be complex; thus, it is beneficial to engage methodo-
logical support from the outset, to build necessary train-
ing requirements into stages of the implementation
process, and to create research and service partnerships
early. Neta et al. recommend an evaluation framework
that highlights the domains required to enhance the
value of implementation and dissemination research for
end users [18]. Application of such an evaluation frame-
work can play an important role in assuring that a
program implemented for research on a small scale is
appropriate for the larger population. While assuring
sustainability of programs that integrate evidence-based
health-promoting practices and behaviors is desirable,
sustainability does not require a program to be frozen in
time. Rather, a characteristic of sustainable programs is
the ability to adapt and change when new knowledge
emerges and needs change.
Finally, it is recommended that clinical trials addressing
effectiveness (as a component of translational research)
retain sufficient flexibility and incorporate intermediate
process evaluations, reflective of the changing needs of
the end users.
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